Off-Label Dermatologic Uses of Anti-TNF-a Therapies

By Alexis Andrew   Strober Bruce  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 296-302

Springer Publishing Company

Access to resources Recommend Favorite

The off-label use of biologic therapies in dermatology

By Lee Natasha   Savage Laura Jane  

Dermatological Nursing, Vol. 14, Iss. 1, 2015-03 ,pp. : 52-56

British Dermatological Nursing Group

Access to resources Recommend Favorite

Open label trial of alefacept in palmoplantar pustular psoriasis

By Carr David   Tusa Mark   Carroll Christie   Pearce Daniel   Camacho Fabian   Kaur Mandeep   Cook Christina   Willard Joy   McCarty Ann   Fleischer Alan   Liu Clive   Goffe Bernard   Feldman Steven  

Journal of Dermatological Treatment, Vol. 19, Iss. 2, 2008-01 ,pp. : 97-100

Informa Healthcare

Access to resources Recommend Favorite

The effect of topical corticosteroids in combination with alefacept on circulating T-cell subsets in psoriasis

By Langewouters Annechien   Bovenschen Jorn   De jong Elke   Van Erp Piet   Van De Kerkhof Peter  

Journal of Dermatological Treatment, Vol. 18, Iss. 5, 2007-01 ,pp. : 279-285

Informa Healthcare

Access to resources Recommend Favorite

Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: Interim results of a single-arm, open-label study

By Gattu Shilpa   Busse Kristine   Bhutani Tina   Chiang Charles   Nguyen Thao   Becker Emily   Koo John Y. M.  

Journal of Dermatological Treatment, Vol. 23, Iss. 2, 2012-04 ,pp. : 103-108

Informa Healthcare

Access to resources Recommend Favorite